One standout mechanism involves managing inflammation by guiding immune cells, specifically macrophages, from a pro-inflammatory state (M1 phenotype) to a pro-repair state (M2 phenotype)
Mechanism of Action: Actin Binding & Cell Migration The defining characteristic of TB 500 in research contexts is its actin-sequestering activity
The two are complementary and non-redundant: GHK-Cu for dermis and adnexae, BPC-157+TB-500 for deep structures (tendons, ligaments, muscles, gut)
Administration method: Subcutaneous injection, once a day, for 8 consecutive weeks
Non tested adults, weekend athletes, and people focused on general recovery are a different conversation, but even they should verify their own status